There is a lot to like about MAH. Low PE (7.4), PB (1.0), gross revenue has increased the past three years, solid debt to equity situation and insider buying (although there appears there might be a culture of buying regularly). My assessment of fair share value is at 0.350.
For anyone chasing strong fundamentals I also highly recommend having a look at VYS (nano cap) which has similarly strong fundamentals and but significantly better growth story. DYOR
- Forums
- ASX - By Stock
- MAH
- Under The Radar
Under The Radar, page-12
-
- There are more pages in this discussion • 203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAH (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $808.1M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.0¢ | $446.9K | 1.189M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 156234 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 21211 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 156234 | 0.370 |
6 | 381720 | 0.365 |
8 | 525135 | 0.360 |
5 | 600000 | 0.355 |
4 | 40029 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 21211 | 3 |
0.380 | 138433 | 4 |
0.385 | 27055 | 2 |
0.390 | 112186 | 5 |
0.395 | 627810 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MAH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online